KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E.

Quan Y et al.

NCBI PubMed Central · Papers · License: Open Access

distributed systems architecture

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 418425
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.